Same-Day Discharge After Elective Percutaneous Transcatheter Cardiovascular Interventions

Brayton, 2013, Same-day discharge after percutaneous coronary intervention: a meta-analysis, J Am Coll Cardiol, 62, 275, 10.1016/j.jacc.2013.03.051 Ahn, 2020, Preliminary results of the Outpatient Endovascular and Interventional Society national registry, J Endovasc Ther, 27, 956, 10.1177/1526602820949970 Krishnaswamy, 2022, Feasibility and safety of same-day discharge following transfemoral transcatheter aortic valve replacement, J Am Coll Cardiol Intv, 15, 575, 10.1016/j.jcin.2022.01.013 Barker, 2022, Same-day discharge post–transcatheter aortic valve replacement during the COVID-19 pandemic, J Am Coll Cardiol Intv, 15, 590, 10.1016/j.jcin.2021.12.046 Tan, 2021, Safety and feasibility of same-day discharge after left atrial appendage closure with the Watchman device, Circ Cardiovasc Interv, 14, 10.1161/CIRCINTERVENTIONS.120.009669 Amin, 2018, Association of same-day discharge after elective percutaneous coronary intervention in the United States with costs and outcomes, JAMA Cardiol, 3, 1041, 10.1001/jamacardio.2018.3029 Kim, 2013, Assessing patient-reported outcomes and preferences for same-day discharge after percutaneous coronary intervention: results from a pilot randomized, controlled trial, Circ Cardiovasc Qual Outcomes, 6, 186, 10.1161/CIRCOUTCOMES.111.000069 Rao, 2021, 2021 ACC expert consensus decision pathway on same-day discharge after percutaneous coronary intervention: a report of the American College of Cardiology Solution Set Oversight Committee, J Am Coll Cardiol, 77, 811, 10.1016/j.jacc.2020.11.013 Hauguel, 2017, Management of ambulatory (day case) endovascular procedures for peripheral arterial disease, J Cardiovasc Surg (Torino), 58, 293 Perdoncin, 2021, Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era, Catheter Cardiovasc Interv, 97, 940, 10.1002/ccd.29453 Gilhofer, 2020, Safety and feasibility of same-day discharge after left atrial appendage closure, Can J Cardiol, 36, 945, 10.1016/j.cjca.2020.02.069 Poon, 2021, Medicare two-midnight rule accelerated shift to observation stays, Health Aff (Millwood), 40, 1688, 10.1377/hlthaff.2021.00094 Bradley, 2021, Trends in use and outcomes of same-day discharge following elective percutaneous coronary intervention, J Am Coll Cardiol Intv, 14, 1655, 10.1016/j.jcin.2021.05.043 Heyde, 2007, Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS), Circulation, 115, 2299, 10.1161/CIRCULATIONAHA.105.591495 Bertrand, 2006, A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation, Circulation, 114, 2636, 10.1161/CIRCULATIONAHA.106.638627 Chambers, 2009, Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation, Catheter Cardiovasc Interv, 73, 847, 10.1002/ccd.22100 Gilchrist, 2012, A single center experience with same-day transradial-PCI patients: a contrast with published guidelines, Catheter Cardiovasc Interv, 79, 583, 10.1002/ccd.23159 Rao, 2011, Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients, JAMA, 306, 1461, 10.1001/jama.2011.1409 Clavijo, 2016, Same-day discharge after coronary stenting and femoral artery device closure: a randomized study in stable and low-risk acute coronary syndrome patients, Cardiovasc Revasc Med, 17, 155, 10.1016/j.carrev.2016.03.003 Abdelaal, 2013, Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis, J Am Coll Cardiol Intv, 6, 99, 10.1016/j.jcin.2012.10.008 Masoudi, 2017, Trends in U.S. cardiovascular care: 2016 report from 4 ACC National Cardiovascular Data Registries, J Am Coll Cardiol, 69, 1427, 10.1016/j.jacc.2016.12.005 Ferrante, 2016, Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials, J Am Coll Cardiol Intv, 9, 1419, 10.1016/j.jcin.2016.04.014 Seto, 2018, Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions, Catheter Cardiovasc Interv, 92, 717, 10.1002/ccd.27637 Bundhun, 2017, Same day discharge versus overnight stay in the hospital following percutaneous coronary intervention in patients with stable coronary artery disease: a systematic review and meta-analysis of randomized controlled trials, PLoS ONE, 12, 10.1371/journal.pone.0169807 Taxiarchi, 2019, Same-day discharge after elective percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society, J Am Coll Cardiol Intv, 12, 1479, 10.1016/j.jcin.2019.03.030 Madan, 2019, Same-day discharge after elective percutaneous coronary interventions in Ontario, Canada, J Am Heart Assoc, 8 Koutouzis, 2021, Same day discharge after chronic total occlusion interventions: a single center experience, Catheter Cardiovasc Interv, 98, 1232, 10.1002/ccd.29320 Taxiarchi, 2022, Same-day discharge after elective percutaneous coronary intervention for chronic total occlusion in the UK, J Invasive Cardiol, 34, E179 Glaser, 2009, Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention, J Invasive Cardiol, 21, 464 Rinfret, 2010, Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen, J Am Coll Cardiol Intv, 3, 1011, 10.1016/j.jcin.2010.07.011 Amin, 2017, Costs associated with access site and same-day discharge among Medicare beneficiaries undergoing percutaneous coronary intervention: an evaluation of the current percutaneous coronary intervention care pathways in the United States, J Am Coll Cardiol Intv, 10, 342, 10.1016/j.jcin.2016.11.049 Schulz-Schupke, 2014, Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial, JAMA, 312, 1981, 10.1001/jama.2014.15305 Wong, 2009, A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure’s Vascular Closure Device Speeds Hemostasis Trial), J Am Coll Cardiol Intv, 2, 785, 10.1016/j.jcin.2009.06.006 Slone, 2021, Implementation of an accelerated discharge process following percutaneous coronary intervention for patients with non-ST elevation acute coronary syndromes, Eur J Cardiovasc Nurs, 20, 660, 10.1093/eurjcn/zvaa029 Ghanbari, 2021, Safety of same-day discharge after percutaneous coronary intervention in selected patients with non-ST elevation acute coronary syndrome, J Invasive Cardiol, 33, E156 Hariri, 2022, Same day discharge following non-elective PCI for non-ST elevation acute coronary syndromes, Am Heart J, 246, 125, 10.1016/j.ahj.2021.12.015 Kandan, 2019, Management of percutaneous coronary intervention complications, Heart, 105, 75, 10.1136/heartjnl-2017-311155 Doll, 2020, Management of percutaneous coronary intervention complications: algorithms from the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference, Circ Cardiovasc Interv, 13, 10.1161/CIRCINTERVENTIONS.120.008962 Jabara, 2008, Ambulatory discharge after transradial coronary intervention: preliminary US single-center experience (Same-Day Transradial Intervention and Discharge Evaluation, the STRIDE study), Am Heart J, 156, 1141, 10.1016/j.ahj.2008.07.018 Small, 2007, Day procedure intervention is safe and complication free in higher risk patients undergoing transradial angioplasty and stenting. The DISCHARGE study, Catheter Cardiovasc Interv, 70, 907, 10.1002/ccd.21277 Writing Committee, 2022, 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, J Am Coll Cardiol, 79, e21, 10.1016/j.jacc.2021.09.006 Gerhard-Herman, 2017, 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 69, e71, 10.1016/j.jacc.2016.11.007 Mohapatra, 2020, Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries, J Vasc Surg, 71, 560, 10.1016/j.jvs.2019.05.034 Rowe, 2009, Patterns of treatment for peripheral arterial disease in the United States: 1996-2005, J Vasc Surg, 49, 910, 10.1016/j.jvs.2008.11.054 2007, Medicare program; prospective payment system for long-term care hospitals RY 2008: annual payment rate updates, and policy changes; and hospital direct and indirect graduate medical education policy changes. Final rule, Fed Regist, 72, 26869 Jones, 2015, Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system, J Am Coll Cardiol, 65, 920, 10.1016/j.jacc.2014.12.048 Gouicem, 2014, Feasibility of ambulatory percutaneous femoral access without the use of arterial closure systems, Ann Vasc Surg, 28, 132, 10.1016/j.avsg.2013.06.007 Spiliopoulos, 2016, Day-case treatment of peripheral arterial disease: results from a multi-center European study, Cardiovasc Intervent Radiol, 39, 1684, 10.1007/s00270-016-1436-9 Ansari, 2020, Safety of day-case endovascular interventions for peripheral arterial disease in a rural, underserved area, Ther Adv Cardiovasc Dis, 14, 10.1177/1753944720948651 Kwan, 2015, Feasibility and safety of routine transpedal arterial access for treatment of peripheral artery disease, J Invasive Cardiol, 27, 327 Jain, 2014, Office-based endovascular suite is safe for most procedures, J Vasc Surg, 59, 186, 10.1016/j.jvs.2013.07.008 Huang, 2008, Day-case diagnostic and interventional peripheral angiography: 10-year experience in a radiology specialist nurse-led unit, Br J Radiol, 81, 537, 10.1259/bjr/54749779 Islam, 2018, Feasibility, safety, and patient satisfaction of same-day discharge following peripheral arterial interventions: a randomized controlled study, Catheter Cardiovasc Interv, 92, 358, 10.1002/ccd.27580 Kruse, 2000, Safety of short stay observation after peripheral vascular intervention, J Vasc Interv Radiol, 11, 45, 10.1016/S1051-0443(07)61277-9 Burns, 2000, The timing and frequency of complications after peripheral percutaneous transluminal angioplasty and iliac stenting: is a change from inpatient to outpatient therapy feasible?, Cardiovasc Intervent Radiol, 23, 452, 10.1007/s002700010103 Levin, 2022, Percutaneous radial artery access for peripheral vascular interventions is a safe alternative for upper extremity access, J Vasc Surg, 76, 174, 10.1016/j.jvs.2021.11.076 Ortiz, 2014, Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes, Circ Cardiovasc Interv, 7, 821, 10.1161/CIRCINTERVENTIONS.114.001306 Bhardwaj, 2019, Bleeding complications in lower-extremity peripheral vascular interventions: insights from the NCDR PVI Registry, J Am Coll Cardiol Intv, 12, 1140, 10.1016/j.jcin.2019.03.012 Safley, 2021, Acute kidney injury following in-patient lower extremity vascular intervention: from the National Cardiovascular Data Registry, J Am Coll Cardiol Intv, 14, 333, 10.1016/j.jcin.2020.10.028 Carroll, 2020, STS-ACC TVT Registry of transcatheter aortic valve replacement, J Am Coll Cardiol, 76, 2492, 10.1016/j.jacc.2020.09.595 Wood, 2019, The Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study, J Am Coll Cardiol Intv, 12, 459, 10.1016/j.jcin.2018.12.020 Pop, 2021, Same day discharge during the COVID-19 pandemic in highly selected transcatheter aortic valve replacement patients, Structural Heart, 5, 596, 10.1080/24748706.2021.1988780 Giri, 2022, Did the COVID-19 pandemic just turn TAVR into an outpatient procedure?, J Am Coll Cardiol Intv, 15, 599, 10.1016/j.jcin.2022.02.004 Vemulapalli, 2019, Procedural volume and outcomes for transcatheter aortic-valve replacement, N Engl J Med, 380, 2541, 10.1056/NEJMsa1901109 Sanchez, 2020, Predictors and risk calculator of early unplanned hospital readmission following contemporary self-expanding transcatheter aortic valve replacement from the STS/ACC TVT Registry, Cardiovasc Revasc Med, 21, 263, 10.1016/j.carrev.2019.05.032 Kolte, 2017, Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the Nationwide Readmissions Database, Circ Cardiovasc Interv, 10, 10.1161/CIRCINTERVENTIONS.116.004472 Abawi, 2016, Incidence, predictive factors, and effect of delirium after transcatheter aortic valve replacement, J Am Coll Cardiol Intv, 9, 160, 10.1016/j.jcin.2015.09.037 Mangieri, 2018, Predictors of advanced conduction disturbances requiring a late (>/=48 h) permanent pacemaker following transcatheter aortic valve replacement, J Am Coll Cardiol Intv, 11, 1519, 10.1016/j.jcin.2018.06.014 Ream, 2019, Ambulatory rhythm monitoring to detect late high-grade atrioventricular block following transcatheter aortic valve replacement, J Am Coll Cardiol, 73, 2538, 10.1016/j.jacc.2019.02.068 Rodes-Cabau, 2018, Arrhythmic burden as determined by ambulatory continuous cardiac monitoring in patients with new-onset persistent left bundle branch block following transcatheter aortic valve replacement: the MARE study, J Am Coll Cardiol Intv, 11, 1495, 10.1016/j.jcin.2018.04.016 Isogai, 2022, Early resolution of new-onset left bundle branch block after transcatheter aortic valve implantation with the SAPIEN 3 valve, Am J Cardiol, 168, 117, 10.1016/j.amjcard.2021.12.032 Rodés-Cabau, 2019, Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel, J Am Coll Cardiol, 74, 1086, 10.1016/j.jacc.2019.07.014 Reiter, 2021, Delayed total atrioventricular block after transcatheter aortic valve replacement assessed by implantable loop recorders, J Am Coll Cardiol Intv, 14, 2723, 10.1016/j.jcin.2021.09.003 Muntane-Carol, 2021, Ambulatory electrocardiographic monitoring following minimalist transcatheter aortic valve replacement, J Am Coll Cardiol Intv, 14, 2711, 10.1016/j.jcin.2021.08.039 Muntane-Carol, 2021, Ambulatory electrocardiogram monitoring in patients undergoing transcatheter aortic valve replacement: JACC state-of-the-art review, J Am Coll Cardiol, 77, 1344, 10.1016/j.jacc.2020.12.062 Krishnaswamy, 2020, The utility of rapid atrial pacing immediately post-TAVR to predict the need for pacemaker implantation, J Am Coll Cardiol Intv, 13, 1046, 10.1016/j.jcin.2020.01.215 Writing Committee, 2021, 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, J Am Coll Cardiol, 77, e25, 10.1016/j.jacc.2020.11.018 Mack, 2021, Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT Registry, J Am Coll Cardiol, 78, 2326, 10.1016/j.jacc.2021.07.058 Chowdhury, 2021, Same-day discharge after transcatheter mitral valve repair using MitraClip in a tertiary community hospital: a case series, Eur Heart J Case Rep, 5, ytab397, 10.1093/ehjcr/ytab397 Marmagkiolis, 2021, Feasibility of same-day discharge approach after transcatheter mitral valve repair procedures, J Invasive Cardiol, 33, E123 Jobs, 2021, Deep sedation versus general anaesthesia for transcatheter mitral valve repair: an individual patient data meta-analysis of observational studies, EuroIntervention, 16, 1359, 10.4244/EIJ-D-20-00607 Steppich, 2018, Vascular complications after percutaneous mitral valve repair and venous access closure using suture or closure device, J Interv Cardiol, 31, 223, 10.1111/joic.12459 Geis, 2015, Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair, EuroIntervention, 10, 1346, 10.4244/EIJV10I11A231 January, 2019, J Am Coll Cardiol, 74, 104, 10.1016/j.jacc.2019.01.011 Reddy, 2013, Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial, Circulation, 127, 720, 10.1161/CIRCULATIONAHA.112.114389 Holmes, 2014, Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial, J Am Coll Cardiol, 64, 1, 10.1016/j.jacc.2014.04.029 Vuddanda, 2020, Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: a US nationwide retrospective cohort study using claims data, Heart Rhythm, 17, 374, 10.1016/j.hrthm.2019.09.018 Osmancik, 2020, Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation, J Am Coll Cardiol, 75, 3122, 10.1016/j.jacc.2020.04.067 Boersma, 2017, Efficacy and safety of left atrial appendage closure with Watchman in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial, Heart Rhythm, 14, 1302, 10.1016/j.hrthm.2017.05.038 Freeman, 2020, The NCDR Left Atrial Appendage Occlusion Registry, J Am Coll Cardiol, 75, 1503, 10.1016/j.jacc.2019.12.040 Lakkireddy, 2021, Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): a randomized, controlled trial, Circulation, 144, 1543, 10.1161/CIRCULATIONAHA.121.057063 Marmagkiolis, 2021, Effectiveness and safety of same day discharge after left atrial appendage closure under moderate conscious sedation, Catheter Cardiovasc Interv, 97, 912, 10.1002/ccd.29376 Dallan, 2022, Safety, efficacy, and cost-effectiveness of same-day discharge for left atrial appendage occlusion, J Invasive Cardiol, 34, E124 Piayda, 2021, Length of stay following percutaneous left atrial appendage occlusion: data from the prospective, multicenter Amplatzer Amulet occluder observational study, PLoS ONE, 16, 10.1371/journal.pone.0255721 Kar, 2021, Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial, Circulation, 143, 1754, 10.1161/CIRCULATIONAHA.120.050117 Kapadia S. Real-world outcomes with Watchman FLX: early results from SURPASS. Presented at: CRT22; February 28, 2022. Gibson, 2022, Safety and effectiveness of same day discharge after left atrial appendage occlusion with Watchman FLX, Presented at: Heart Rhythm Nielsen-Kudsk, 2019, Use of intracardiac compared with transesophageal echocardiography for left atrial appendage occlusion in the Amulet observational study, J Am Coll Cardiol Intv, 12, 1030, 10.1016/j.jcin.2019.04.035 Alkhouli, 2020, Outcomes of routine intracardiac echocardiography to guide left atrial appendage occlusion, J Am Coll Cardiol EP, 6, 393 Isogai, 2021, Incidence and outcomes of pericardial effusion/tamponade following percutaneous left atrial appendage closure, Am J Cardiol, 160, 126, 10.1016/j.amjcard.2021.08.028 Stout, 2019, 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 73, e81, 10.1016/j.jacc.2018.08.1029 Mas, 2017, Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke, N Engl J Med, 377, 1011, 10.1056/NEJMoa1705915 Saver, 2017, Long-term outcomes of patent foramen ovale closure or medical therapy after stroke, N Engl J Med, 377, 1022, 10.1056/NEJMoa1610057 Bijl, 2005, Percutaneous closure of patent foramen ovale, Intern Med J, 35, 706, 10.1111/j.1445-5994.2005.00948.x Ponnuthurai, 2009, Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography, Int J Cardiol, 131, 438, 10.1016/j.ijcard.2007.07.141 Barker, 2020, Periprocedural outcomes of fluoroscopy-guided patent foramen ovale closure with selective use of intracardiac echocardiography, Can J Cardiol, 36, 1608, 10.1016/j.cjca.2019.12.032 Prashar, 2021, Safety and cost implications of same-day discharge following elective percutaneous closure of patent foramen ovale and atrial septal defects in Australia, Hearts, 2, 543, 10.3390/hearts2040041 Turner, 2017, Closure of secundum atrial septal defects with the Amplatzer Septal Occluder: a prospective, multicenter, post-approval study, Circ Cardiovasc Interv, 10, 10.1161/CIRCINTERVENTIONS.116.004212 Abaci, 2013, Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies, Catheter Cardiovasc Interv, 82, 1123, 10.1002/ccd.24875